Beranda › Penyakit Parkinson › Washington
Uji klinis Penyakit Parkinson di Washington
15 studi untuk Penyakit Parkinson mencari peserta di lokasi di Washington.
Kota di Washington
Teks studi resmi (Bahasa Inggris)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- EvergreenHealth, Kirkland
- Inland Northwest Research, Spokane
Menerima pesertaFase 2
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06680830A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-007, Bellevue
- Site-019, Seattle
Menerima pesertaFase 2/3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06976268A Study of Buntanetap in Participants With PD
- Inland Northwest Research, Spokane
Menerima pesertaFase 2/3
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07284784Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- Inland Northwest Research, Spokane
Menerima pesertaFase 2
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07005180Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Evergreen Health, Kirkland
- Virginia Mason Medical Center, Seattle
- University of Washington Medical Center, Seattle
- dan 1 lainnya
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #023, Kirkland
- Vima Site #015, Spokane
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- EvergreenHealth (Site #219), Kirkland
Menerima pesertaFase 2
Usia 30 hingga 80 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- Evergreen Health, Kirkland
- Inland Northwest Research, Spokane
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- VA Puget Sound Health Care System, Seattle
Menerima pesertaStudi observasional
Usia 45 hingga 75 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07330258A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- EvergreenHealth - Research Department, Kirkland
Menerima pesertaFase 3
Usia 45 hingga 75 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Univ of Washington and VA Puget Sound Health Care System, Seattle
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT04477785Use of CereGate Therapy for Freezing of Gait in PD
- University of Washington, Seattle
Menerima peserta
Usia 21 hingga 80 · Semua jenis kelamin · Diperbarui 28 Mei 2026 · NCT05292794A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- Evergreen Health Research, Kirkland
- Inland Northwest Research, Spokane
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 30 hingga 85 · Semua jenis kelamin · Diperbarui 20 Apr 2026 · NCT06809400The Parkinson's Genetic Research Study
- VA Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2024 · NCT01558479Modifiable Variables in Parkinsonism (MVP)
- Bastyr University, Kenmore
Menerima pesertaStudi observasional
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 25 Mar 2022 · NCT02194816Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.